Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies
J Trotman, S Luminari, S Boussetta, A Versari… - The Lancet …, 2014 - thelancet.com
Background The value of 18 F-fluorodeoxyglucose (FDG) PET-CT (PET) imaging in
response assessment after first-line rituximab chemotherapy for follicular lymphoma has …
response assessment after first-line rituximab chemotherapy for follicular lymphoma has …
PET/CT for lymphoma post-therapy response assessment in other lymphomas, response assessment for autologous stem cell transplant, and lymphoma follow-up
FDG-PET/CT is an established first-line diagnostic imaging tool used in the staging of most
lymphomas and for post-therapy response assessment in Hodgkin lymphoma (HL) and …
lymphomas and for post-therapy response assessment in Hodgkin lymphoma (HL) and …
Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population
L Magnano, S Alonso‐Alvarez… - British Journal of …, 2019 - Wiley Online Library
The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL).
Recently, complete response at 30 months (CR 30) has been suggested as a surrogate for …
Recently, complete response at 30 months (CR 30) has been suggested as a surrogate for …
Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma
M Tatsumi, K Isohashi, K Matsunaga, T Watabe… - International Journal of …, 2019 - Springer
Purpose The purpose of this study was to determine if quantitative SUV-related, volumetric
FDG PET parameters, and texture features (SPs, VPs, and TFs, respectively) were useful to …
FDG PET parameters, and texture features (SPs, VPs, and TFs, respectively) were useful to …
Whole‐body MRI‐DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study
AS Littooij, TC Kwee, B de Keizer… - Journal of Magnetic …, 2015 - Wiley Online Library
Background To assess the performance of whole‐body MRI including diffusion‐weighted
imaging (whole‐body MRI‐DWI) for the detection of residual disease after completion of …
imaging (whole‐body MRI‐DWI) for the detection of residual disease after completion of …
Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International …
Purpose To evaluate the accuracy and prognostic value of FDG PET/CT for response
assessment after treatment in patients with Hodgkin lymphoma (HL) and non-Hodgkin …
assessment after treatment in patients with Hodgkin lymphoma (HL) and non-Hodgkin …
Evidence-based indications for the planning of PET or PET/CT capacities are needed
S Fuchs, N Grössmann, M Ferch, R Busse… - Clinical and Translational …, 2019 - Springer
Purpose To identify evidence-based indications for PET/PET–CT scans in support of
facilities planning and to describe a pilot project in which this information was applied for an …
facilities planning and to describe a pilot project in which this information was applied for an …
Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma
S Draye-Carbonnier, V Camus, S Becker… - Scientific Reports, 2024 - nature.com
The prognostic value of radiomic quantitative features measured on pre-treatment 18F-FDG
PET/CT was investigated in patients with follicular lymphoma (FL). We conducted a …
PET/CT was investigated in patients with follicular lymphoma (FL). We conducted a …
Clinical application of [18F] FDG PET/CT in follicular lymphoma
A Díaz-Silván, LF Otón-Sánchez… - Revista Española de …, 2022 - Elsevier
The objective of the present paper was to review the clinical application of [18 F] FDG
PET/CT in follicular lymphoma (FL). Once it was clear that, despite it is characterized as …
PET/CT in follicular lymphoma (FL). Once it was clear that, despite it is characterized as …
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS study
L Kostakoglu, A Goy, G Martinelli… - Leukemia & …, 2017 - Taylor & Francis
An exploratory analysis of 75 follicular lymphoma patients treated with obinutuzumab or
rituximab induction therapy (IT) for 4 weeks in the phase II GAUSS study aimed to determine …
rituximab induction therapy (IT) for 4 weeks in the phase II GAUSS study aimed to determine …